Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Medicinal Chemistry|April 3, 2001
The 2-chlorotrityl resin: a worthy addition to the medicinal chemist's toolboxW J HoekstraThe Prostate|January 1, 1981
The role of lymphangiography in the staging of prostatic cancerW J Hoekstra, F H SchroederCurrent Medicinal Chemistry|July 1, 1998
Combinatorial chemistry techniques applied to nonpeptide integrin antagonistsW J Hoekstra, B L PoulterThe Journal of Urology|August 1, 1985
Early orchiectomy for patients with stage D1 prostatic carcinomaO G van Aubel, W J Hoekstra, F H SchröderBioorganic & Medicinal Chemistry Letters|February 18, 1999
Photoactivatable peptides based on BMS-197525: a potent antagonist of the human thrombin receptor (PAR-1)J T Elliott, W J Hoekstra, B E Maryanoff, et al.The Journal of Urology|November 1, 1983
Urogenital tract abnormalities associated with congenital anorectal anomaliesW J Hoekstra, R J Scholtmeijer, J C Molenaar, et al.Antimicrobial Agents and Chemotherapy|January 22, 2015
VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig modelE P Garvey, W J Hoekstra, W R Moore, et al.Antimicrobial Agents and Chemotherapy|December 14, 2016
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong <i>In Vitro</i> Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal CompoundsW A Schell, A M Jones, E P Garvey, et al.Antimicrobial Agents and Chemotherapy|July 1, 2015
Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasisE P Garvey, W J Hoekstra, R J Schotzinger, et al.Biochimica Et Biophysica Acta|August 15, 1996
NOE-derived conformation of GRGDSP cell adhesion recognition site in the presence of SDS micelles and integrin receptor GPIIB/IIIAK H Mayo, F Fan, M P Beavers, et al.Pageof 3